A prospective study of hormone therapy and depression in community-dwelling elderly women: The three city study

Journal of Clinical Psychiatry

Volumn 71, Issue 12, 2010, Pages 1673-1679

  Scali, Jacqueline ^a   Ryan, Joanne ^a   Carrière, Isabelle ^a   Dartigues, Jean François ^b   Tavernier, Béatrice ^c   Ritchie, Karen ^a   Ancelin, Marie Laure ^a  

^a Montpellier 1 University   (France)

^b INSERM   (France)

^c Geriatric Medical Center Champmaillot   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; GESTAGEN;

AGED; ARTICLE; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; COGNITIVE DEFECT; COMMUNITY SAMPLE; DEPRESSION; DRUG EFFECT; FEMALE; FOLLOW UP; FRANCE; HEALTH STATUS; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ADMINISTRATION, CUTANEOUS; AGED; AGED, 80 AND OVER; DEPRESSION; DRUG THERAPY, COMBINATION; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; FOLLOW-UP STUDIES; FRANCE; HUMANS; INCIDENCE; LOGISTIC MODELS; MEDICATION ADHERENCE; MULTIVARIATE ANALYSIS; ODDS RATIO; POSTMENOPAUSE; PROGESTERONE CONGENERS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 78650474950     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.09m05188blu     Document Type: Article

References (41)

1. Ancelin ML, Scali J, Ritchie K. Hormonal therapy and depression: are we overlooking an important therapeutic alternative? J Psychosom Res. 2007;62(4):473-485.
2. Schmidt PJ, Nieman L, Danaceau MA, et al. Estrogen replacement in perimenopause-related depression: a preliminary report. Am J Obstet Gynecol. 2000;183(2):414-420.
3. Soares CN, Almeida OP, Joffe H, et al. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial. Arch Gen Psychiatry. 2001;58(6):529-534.
4. Cohen LS, Soares CN, Poitras JR, et al. Short-term use of estradiol for depression in perimenopausal and postmenopausal women: a preliminary report. Am J Psychiatry. 2003;160(8):1519-1522.
5. Morrison MF, Kallan MJ, Ten Have T, et al. Lack of efficacy of estradiol for depression in postmenopausal women: a randomized, controlled trial. Biol Psychiatry. 2004;55(4):406-412. (Pubitemid 38199991)
6. Zweifel JE, O'Brien WH. A meta-analysis of the effect of hormone replacement therapy upon depressed mood. Psychoneuroendocrinology. 1997;22(3):189-212. (Pubitemid 27293623)
7. Rymer J, Morris EP. Extracts from "Clinical evidence": menopausal symptoms. BMJ. 2000;321(7275):1516-1519.
8. Soares CN, Arsenio H, Joffe H, et al. Escitalopram versus ethinyl estradiol and norethindrone acetate for symptomatic peri- and postmenopausal women: impact on depression, vasomotor symptoms, sleep, and quality of life. Menopause. 2006;13(5):780-786.
9. Rossouw JE, Anderson GL, Prentice RL, et al. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288(3):321-333.
10. 3C Study Group. Vascular factors and risk of dementia: design of the Three-City Study and baseline characteristics of the study population. Neuroepidemiology. 2003;22(6):316-325.
11. Berkman LF, Berkman CS, Kasl S, et al. Depressive symptoms in relation to physical health and functioning in the elderly. Am J Epidemiol. 1986;124(3):372-388.
12. Radloff LS, Locke BZ. The Community Mental Health Assessment Survey and CES-D scale. New Brunswick, NJ: Rutgers University Press; 1986.
13. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(suppl 20):22-33, quiz 34-57.
14. Ritchie K, Artero S, Beluche I, et al. Prevalence of DSM-IV psychiatric disorder in the French elderly population. Br J Psychiatry. 2004;184(2):147-152.
15. Lawton MP. Scales to measure competence in everyday activities. Psychopharmacol Bull. 1988;24(4):609-614.
16. Katz S, Ford AB, Moskowitz RW, et al. Studies of illness in the aged: the index of ADL: a standardized measure of biological and psychosocial function. JAMA. 1963;185:914-919.
17. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189-198.
18. Ribet C, Derriennic F. Age, working conditions, and sleep disorders: a longitudinal analysis in the French cohort E.S.T.E.V. Sleep. 1999;22(4):491-504.
19. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994.
20. Resnick SM, Henderson VW. Hormone therapy and risk of Alzheimer disease: a critical time. JAMA. 2002;288(17):2170-2172.
21. Zandi PP, Carlson MC, Plassman BL, et al. Cache County Memory Study Investigators. Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. JAMA. 2002;288(17):2123-2129.
22. Whooley MA, Grady D, Cauley JA. Postmenopausal estrogen therapy and depressive symptoms in older women. J Gen Intern Med. 2000;15(8): 535-541.
23. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1(3):385-401.
24. Ancelin ML, Ritchie K. Lifelong endocrine fluctuations and related cognitive disorders. Curr Pharm Des. 2005;11(32):4229-4252.
25. Fitzpatrick LA, Pace C, Wiita B. Comparison of regimens containing oral micronized progesterone or medroxyprogesterone acetate on quality of life in postmenopausal women: a cross-sectional survey. J Womens Health Gend Based Med. 2000;9(4):381-387.
26. Sherwin BB. The impact of different doses of estrogen and progestin on mood and sexual behavior in postmenopausal women. J Clin Endocrinol Metab. 1991;72(2):336-343.
27. Björn I, Bixo M, Nöjd KS, et al. Negative mood changes during hormone replacement therapy: a comparison between two progestogens. Am J Obstet Gynecol. 2000;183(6):1419-1426.
28. Andréen L, Bixo M, Nyberg S, et al. Progesterone effects during sequential hormone replacement therapy. Eur J Endocrinol. 2003;148(5):571-577. (Pubitemid 36622166)
29. Odmark IS, Bäckström T, Jonsson B, et al. Well-being at onset of hormone replacement therapy: comparison between two continuous combined regimens. Climacteric. 2004;7(1):92-102. (Pubitemid 38372139)
30. Cummings JA, Brizendine L. Comparison of physical and emotional side effects of progesterone or medroxyprogesterone in early postmenopausal women. Menopause. 2002;9(4):253-263. (Pubitemid 34743450)
31. Cagnacci A, Arangino S, Baldassari F, et al. A comparison of the central effects of different progestins used in hormone replacement therapy. Maturitas. 2004;48(4):456-462. (Pubitemid 38993261)
32. Cohen LS, Soares CN, Vitonis AF, et al. Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles. Arch Gen Psychiatry. 2006;63(4):385-390.
33. Col NF, Guthrie JR, Politi M, et al. Duration of vasomotor symptoms in middle-aged women: a longitudinal study. Menopause. 2009;16(3): 453-457.
34. Woods NF, Smith-DiJulio K, Percival DB, et al. Depressed mood during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women's Health Study. Menopause. 2008;15(2): 223-232. (Pubitemid 351354981)
35. Soares CN. Depression during the menopausal transition: window of vulnerability or continuum of risk? Menopause. 2008;15(2):207-209.
36. McIntyre RS, Konarski JZ, Grigoriadis S, et al. Hormone replacement therapy and antidepressant prescription patterns: a reciprocal relationship. CMAJ. 2005;172(1):57-59.
37. Cohen LS, Soares CN, Joffe H. Diagnosis and management of mood disorders during the menopausal transition. Am J Med. 2005; 118(suppl 12B):93-97.
38. Soares CN, Joffe H, Viguera AC, et al. Paroxetine versus placebo for women in midlife after hormone therapy discontinuation. Am J Med. 2008;121(2):159-162, e1.
39. Altshuler LL, Cohen LS, Moline ML, et al. Expert Consensus Panel for Depression in Women. The Expert Consensus Guideline Series: treatment of depression in women. Postgrad Med. 2001;(Spec No):1-107.
40. Skouby SO, Al-Azzawi F, Barlow D, et al. European Menopause and Andropause Society. Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy. Maturitas. 2005;51(1): 8-14.
41. Grady D, Sawaya GF. Discontinuation of postmenopausal hormone therapy. Am J Med. 2005;118(suppl 12B):163-165.